Physician profile
John Carraher
NPI 1689657967
$1,836.51
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $243 · 2021: $386 · 2022: $261 · 2023: $364 · 2024: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $562.39 | 2019-2024 | Lithovue, Nephromax, Rezum Generator |
| Astellas Pharma US INC | $271.88 | 2019-2022 | |
| Abbvie INC. | $146.91 | 2019-2023 | Lupron Depot |
| Neotract INC. | $93.95 | 2020 | |
| Blue Earth Diagnostics | $91.56 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $75.93 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $48.88 | 2019 | |
| Laborie Medical Technologies Corp. | $43.78 | 2021-2024 | Endosheath Technology |
| Allergan, INC. | $42.93 | 2019-2020 | |
| Pfizer INC. | $42.78 | 2022-2023 | |
| Coloplast Corp | $40.37 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $39.12 | 2023 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $39.05 | 2021-2023 | Jelmyto |
| Teleflex LLC | $38.65 | 2022-2023 | Urolift |
| Olympus America INC. | $34.53 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $33.49 | 2020 | |
| Ferring Pharmaceuticals INC. | $33.20 | 2019 | |
| Axonics, INC. | $32.42 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $28.38 | 2019 | |
| 180 Medical, INC. | $21.20 | 2023 | Gentlecath Glide |
| Myovant Sciences INC. | $19.96 | 2022 | |
| Procept Biorobotics Corporation | $15.86 | 2019 | |
| Janssen Biotech, INC. | $13.93 | 2021 | |
| Rochester Medical Corporation | $13.16 | 2019 | |
| Foundation Medicine, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Carraher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.